[go: up one dir, main page]

WO1994004184A3 - Method of decreasing cutaneous senescence - Google Patents

Method of decreasing cutaneous senescence Download PDF

Info

Publication number
WO1994004184A3
WO1994004184A3 PCT/US1993/007470 US9307470W WO9404184A3 WO 1994004184 A3 WO1994004184 A3 WO 1994004184A3 US 9307470 W US9307470 W US 9307470W WO 9404184 A3 WO9404184 A3 WO 9404184A3
Authority
WO
WIPO (PCT)
Prior art keywords
senescence
cutaneous senescence
decreasing
decreasing cutaneous
human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US1993/007470
Other languages
French (fr)
Other versions
WO1994004184A2 (en
Inventor
Gregory L Brown
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bays-Brown Dermatologics Inc
Original Assignee
Bays-Brown Dermatologics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bays-Brown Dermatologics Inc filed Critical Bays-Brown Dermatologics Inc
Priority to AU50017/93A priority Critical patent/AU5001793A/en
Publication of WO1994004184A2 publication Critical patent/WO1994004184A2/en
Publication of WO1994004184A3 publication Critical patent/WO1994004184A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1808—Epidermal growth factor [EGF] urogastrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1825—Fibroblast growth factor [FGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1858—Platelet-derived growth factor [PDGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/30—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Epidermal cell, and thereby cutaneous senescence in a human is decreased by topically administering to human skin an effective amount of a protein growth factor optionally in a pharmaceutically or cosmetically acceptable carrier.
PCT/US1993/007470 1992-08-12 1993-08-10 Method of decreasing cutaneous senescence Ceased WO1994004184A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU50017/93A AU5001793A (en) 1992-08-12 1993-08-10 Method of decreasing cutaneous senescence

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US92826492A 1992-08-12 1992-08-12
US07/928,264 1992-08-12

Publications (2)

Publication Number Publication Date
WO1994004184A2 WO1994004184A2 (en) 1994-03-03
WO1994004184A3 true WO1994004184A3 (en) 1994-06-23

Family

ID=25455979

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1993/007470 Ceased WO1994004184A2 (en) 1992-08-12 1993-08-10 Method of decreasing cutaneous senescence

Country Status (2)

Country Link
AU (1) AU5001793A (en)
WO (1) WO1994004184A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR1002807B (en) 1996-06-20 1997-11-13 Lavipharm A.E. Device for topical treatment of acne and method of manufacture.
US6306432B1 (en) * 1997-09-08 2001-10-23 Chiron Corporation High and low load formulations of IGF-I in multivesicular liposomes
FR2828401B1 (en) * 2001-08-10 2003-11-07 Oreal COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING AN ASSOCIATION BETWEEN IGF1 AND / OR A MIMETIC COMPOUND OF IGF1, AND ASCORBIC ACID AND / OR AT LEAST ONE OF ITS DERIVATIVES
FR2828400B1 (en) * 2001-08-10 2003-11-07 Oreal COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING AN ASSOCIATION BETWEEN IGF1 AND / OR AN IGF1 MIMETIC COMPOUND, AND AT LEAST ONE RETINOIDE AND / OR AT LEAST ONE RETINOID DERIVATIVE
US6821524B2 (en) * 2002-06-03 2004-11-23 Jan Marini Skin Research, Inc. Cosmetic skin care compositions
FR2854328B1 (en) * 2003-04-29 2006-08-04 Rocher Yves Biolog Vegetale COSMETIC OR DERMATOLOGICAL OR PHARMACEUTICAL COMPOSITION CONTAINING A PEPTIDE-LIKE GROWTH FACTOR OF PLANT TYPE
US8673859B2 (en) 2007-03-20 2014-03-18 New York University GM-CSF cosmeceutical compositions and methods of use thereof
WO2008116111A2 (en) * 2007-03-20 2008-09-25 Harold Brem Growth factor mediated cosmeceuticals and use thereof to enhance skin quality
US9808654B2 (en) 2013-02-11 2017-11-07 Jan Marini Skin Research Post procedure skin care gel and methods of use thereof

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS615006A (en) * 1984-06-19 1986-01-10 Sanki Shoji Kk Agent for skin
JPS6115810A (en) * 1984-06-30 1986-01-23 Nonogawa Shoji:Kk Cosmetic
JPS6219511A (en) * 1985-07-19 1987-01-28 Kanebo Ltd Cosmetic for preventing aging of skin
FR2654342A1 (en) * 1989-11-16 1991-05-17 Sodichimic Sa Pharmaceutical and/or cosmetic composition containing a hypophyseal growth factor (HDGF) stabilised with soluble elastin
EP0444638A2 (en) * 1990-02-27 1991-09-04 FIDIA S.p.A. Process for the expression of human nerve growth factor in arthropoda frugiperda cells by infection with recombinant baculovirus
WO1991018999A1 (en) * 1990-06-04 1991-12-12 Levin Robert H Yeast-derived epidermal growth factor/urogastrone-like products
JPH0429916A (en) * 1990-05-24 1992-01-31 Shiseido Co Ltd External drug for skin
JPH04145100A (en) * 1990-10-05 1992-05-19 Earth Chem Corp Ltd Polypeptide, drug or cosmetic containing the same as active ingredient and production of said polypeptide
JPH0543442A (en) * 1991-08-14 1993-02-23 Sansho Seiyaku Co Ltd Skin cosmetic

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS615006A (en) * 1984-06-19 1986-01-10 Sanki Shoji Kk Agent for skin
JPS6115810A (en) * 1984-06-30 1986-01-23 Nonogawa Shoji:Kk Cosmetic
JPS6219511A (en) * 1985-07-19 1987-01-28 Kanebo Ltd Cosmetic for preventing aging of skin
FR2654342A1 (en) * 1989-11-16 1991-05-17 Sodichimic Sa Pharmaceutical and/or cosmetic composition containing a hypophyseal growth factor (HDGF) stabilised with soluble elastin
EP0444638A2 (en) * 1990-02-27 1991-09-04 FIDIA S.p.A. Process for the expression of human nerve growth factor in arthropoda frugiperda cells by infection with recombinant baculovirus
JPH0429916A (en) * 1990-05-24 1992-01-31 Shiseido Co Ltd External drug for skin
WO1991018999A1 (en) * 1990-06-04 1991-12-12 Levin Robert H Yeast-derived epidermal growth factor/urogastrone-like products
JPH04145100A (en) * 1990-10-05 1992-05-19 Earth Chem Corp Ltd Polypeptide, drug or cosmetic containing the same as active ingredient and production of said polypeptide
JPH0543442A (en) * 1991-08-14 1993-02-23 Sansho Seiyaku Co Ltd Skin cosmetic

Non-Patent Citations (12)

* Cited by examiner, † Cited by third party
Title
C.C.CHUA ET AL.: "RECEPTOR FOR EPIDERMAL GROWTH FACTOR RETAINS NORMAL STRUCTURE AND FUNCTION IN AGING CELLS", MECHANISMS OF AGEING AND DEVELOPMENT, vol. 34, no. 1, March 1986 (1986-03-01), pages 35 - 55, XP025196818, DOI: doi:10.1016/0047-6374(86)90103-X *
CHEMICAL ABSTRACTS, vol. 104, no. 20, 19 May 1986, Columbus, Ohio, US; abstract no. 174377J *
CHEMICAL ABSTRACTS, vol. 104, no. 22, 2 June 1986, Columbus, Ohio, US; abstract no. 192928U *
CHEMICAL ABSTRACTS, vol. 106, no. 22, 1 June 1987, Columbus, Ohio, US; abstract no. 182467V *
CHEMICAL ABSTRACTS, vol. 115, no. 17, 28 October 1991, Columbus, Ohio, US; abstract no. 176096T *
CHEMICAL ABSTRACTS, vol. 116, no. 24, 15 June 1992, Columbus, Ohio, US; abstract no. 241736P *
CHEMICAL ABSTRACTS, vol. 117, no. 22, 30 November 1992, Columbus, Ohio, US; abstract no. 219741K *
DATABASE WPI Derwent World Patents Index; AN 1993-104177 *
K.KADOWAKI: "DEVELOPMENT OF NEW HOST FOR GENE RECOMBINATION AND POSSIBILITY OF APPLICATION TO COSMETIC PRODUCTS", FRAGRANCE J., vol. 19, no. 7, 1991, pages 99 - 102 *
M.D.HOLLENBERG ET AL.: "RECEPTORS FOR INSULIN AND EPIDERMAL GROWTH FACTOR-UROGASTRONE IN ADULT HUMAN FIBROBLASTS DO NOT CHANGE WITH DONOR AGE", MECH.AGEING DEV., vol. 11, no. 1, August 1979 (1979-08-01), pages 37 - 43, XP023427172, DOI: doi:10.1016/0047-6374(79)90062-9 *
SIR G. ALLEN: "Cosmetics - chemical technology or biotechnology?", INTERNATIONAL JOURNAL OF COSMETIC SCIENCE, vol. 6, no. 2, April 1984 (1984-04-01), pages 61 - 69 *
T.KAWAMOTO ET AL.: "TRANSFORMING GROWTH FACTOR TYPE BETA STIMULATES EPIDERMAL GROWTH FACTOR-DEPENDENT CELL GROWTH OF in vivo AND in vitro SENESCENT HUMAN SKIN FIBROBLASTS.", CELL STRUCT. FUNCT., vol. 13, no. 6, 1988, pages 616 *

Also Published As

Publication number Publication date
WO1994004184A2 (en) 1994-03-03
AU5001793A (en) 1994-03-15

Similar Documents

Publication Publication Date Title
AU5789990A (en) Stable, cosmetically acceptable topical gel formulation and method of treatment for acne
AU3393993A (en) Method of administering proteins to living skin cells
AU3232889A (en) Anti-inflammatory skin moisturizing composition and method of preparing same
EP0342056A3 (en) Cosmetic composition
CA2077144A1 (en) Cosmetic Composition
AU548324B2 (en) Biotin antagonist composition for use on skin and hair
EP0255364A3 (en) Anhydrous cosmetic preparation
AU3232589A (en) Skin cleansing and moisturizing composition and method of using and preparing same
CA2159985A1 (en) Methods of Using Hesperetin for Sebum Control and Treatment of Acne
DE59410301D1 (en) TOPICAL PREPARATIONS WITH A L-ARGININE CONTENT
NZ513154A (en) Therapeutic and/or cosmetic formulations comprising antisense polynucleotides to connexin proteins
AU581121B2 (en) Skin treatment composition
WO1994004184A3 (en) Method of decreasing cutaneous senescence
CA2207783A1 (en) Antiperspirant or deodorant composition comprising a moisturizing cream
EP0197358A3 (en) Topical use of 3-phenylacetylamino-2,6-piperidinedione for treatment of skin wrinkles and hyperpigmentation
ES2137125A1 (en) Use of the zinc salt of glycyrrhetic acid in preparations against acne, and the compositions which contain said salt.
IT1258069B (en) COMPOSITION FOR TOPICAL USE WITH STIMULUS ACTIVITY FOR GROWTH, REGENERATION, PREVENTION OF ENRIGEMENT AND NATURAL REPIGMENTATION OF HAIR
AU7395487A (en) Inhibitors of esterase-producing micro-organisms, for use primarily in dermatology and cosmetics
AU6113286A (en) Epidermal cell extracts and method to enhance wound healing and regenerate epidermis
CA2016351A1 (en) Cosmetic composition
EP0352894A3 (en) Production of cosmetic or pharmaceutical composition
EP0398669A3 (en) Cosmetic composition
AU5405996A (en) Improvements in or relating to cosmetic treatment of skin li nes
EP0276643A3 (en) Composition of a hair growth restorer
AU654850B2 (en) Hydroxyacids for topical treatment of wrinkles and skin changes associated with aging

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AT AU BB BG BR BY CA CH CZ DE DK ES FI GB HU JP KP KR KZ LK LU MG MN MW NL NO NZ PL PT RO RU SD SE SK UA VN

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AT AU BB BG BR BY CA CH CZ DE DK ES FI GB HU JP KP KR KZ LK LU MG MN MW NL NO NZ PL PT RO RU SD SE SK UA VN

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

NENP Non-entry into the national phase

Ref country code: CA

122 Ep: pct application non-entry in european phase